Neurogene (NGNE) Capital Leases (2015 - 2026)
Neurogene's (NGNE) quarterly Capital Leases came in at $4000.0 in Q1 2026, down 76.47% YoY from $17000.0 in Q1 2025, and down 20.0% on a QoQ basis from $5000.0 in Q4 2025.
Neurogene (NGNE) Capital Leases (2015 - 2026) Analysis & Trends
Neurogene (NGNE) has 12 years of Capital Leases data on file, last reported at $4000.0 in Q1 2026.
- Quarterly Capital Leases fell 76.47% year-over-year to $4000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4000.0 (down 76.47% YoY) and the FY2025 annual result came in at $5000.0, down 80.77% from the prior year.
- Capital Leases fell to $4000.0 in Q1 2026, from $5000.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $66000.0 in Q1 2022 to a low of $4000.0 in Q1 2026.
- A 5-year average of $26294.1 and a median of $10000.0 in 2022 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2023 — Capital Leases sank 89.39% — and 2024, when it jumped 783.33%.
- Tracing NGNE's Capital Leases over 5 years: stood at $66000.0 in 2022, then dropped by 1.52% to $65000.0 in 2023, then slumped by 60.0% to $26000.0 in 2024, then plunged by 80.77% to $5000.0 in 2025, then slipped by 20.0% to $4000.0 in 2026.
- The last three Capital Leases figures came in at $4000.0 (Q1 2026), $5000.0 (Q4 2025), and $7000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Neurogene | 815.03 Mn | 815.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,000.00 |
| Mar 31, 2026 | 4,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | 39,000.00 |
| Jun 30, 2024 | 53,000.00 |
| Mar 31, 2024 | 53,000.00 |
| Dec 31, 2023 | 65,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Dec 31, 2022 | 66,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Mar 31, 2022 | 66,000.00 |
| Dec 31, 2021 | 67,000.00 |
| Sep 30, 2021 | 68,000.00 |